EPIPODOPHYLLOTOXIN (VP-16/213) IN SMALL-CELL CARCINOMA OF THE BRONCHUS RESISTANT TO INITIAL COMBINED CHEMOTHERAPY

被引：0
|
作者：
DALLY, MB
HARPER, P
SMYTH, JF
SOUHAMI, RL
GEDDES, DM
SPIRO, SG
机构：
[1] LONDON CHEST HOSP,LONDON,ENGLAND
[2] BROMPTON HOSP,COLLABORAT STUDY GRP,LONDON SW3 6HP,ENGLAND
来源：
BRITISH JOURNAL OF DISEASES OF THE CHEST | 1980年 / 74卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [31] CARBOPLATIN AND VP16-213 WITH RADIOTHERAPY (RT) AS INITIAL TREATMENT FOR PATIENTS WITH SMALL-CELL LUNG-CANCER (SCLC)
    OLVER, IN
    RAGHAVAN, D
    BISHOP, JF
    MORSTYN, G
    KEFFORD, R
    STUARTHARRIS, R
    ARONEY, R
    BALL, D
    FOX, R
    HILLCOAT, B
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 62 - 62
  • [32] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER
    EVANS, WK
    OSOBA, D
    FELD, R
    SHEPHERD, FA
    BAZOS, MJ
    DEBOER, G
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) : 65 - 71
  • [33] VP-16, VINCRISTINE, ADRIAMYCIN AND CYCLOPHOSPHAMIDE (EVAC) IN PATIENTS WITH SMALL-CELL LUNG-CANCER
    ABADESTEVE, A
    ROSELL, R
    MORENO, I
    FERNANDEZMARCIAL, C
    ROSELLO, MR
    MEDICINA CLINICA, 1988, 90 (14): : 569 - 572
  • [34] Elderly (>=75) small-cell lung cancer (SCLC) chemotherapy:: A phase I study of carboplatin (CBDCA) and etoposide (vp-16).
    Fukuda, M
    Oka, M
    Soejima, Y
    Fukuda, M
    Kinoshita, A
    Takatani, H
    Kasai, T
    Kuba, M
    Soda, H
    Kohno, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 670S - 670S
  • [35] ETOPOSIDE (VP-16) AND CYTOSINE-ARABINOSIDE IN THE TREATMENT OF RELAPSED SMALL-CELL LUNG-CANCER
    MARGOLIN, K
    AKMAN, S
    CARR, B
    LEONG, L
    DOROSHOW, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 499 - 501
  • [36] 1ST-LINE THERAPY WITH VP-16 AND CISPLATIN FOR SMALL-CELL LUNG-CANCER
    EVANS, WK
    SHEPHERD, FA
    FELD, R
    OSOBA, D
    DEBOER, G
    SEMINARS IN ONCOLOGY, 1986, 13 (03) : 17 - 23
  • [37] VP-16 AND CISPLATIN AS 1ST-LINE THERAPY FOR SMALL-CELL LUNG-CANCER
    EVANS, WK
    SHEPHERD, FA
    FELD, R
    OSOBA, D
    DANG, P
    DEBOER, G
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) : 1471 - 1477
  • [38] PLATINUM (P) + VP-16 CHEMOTHERAPY FOR REFRACTORY SMALL CELL LUNG-CANCER (RSCLC)
    EINHORN, LH
    WILLIAMS, SD
    LOEHRER, PJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 174 - 174
  • [39] VP-16-213 CHEMOTHERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF LUNG
    EAGAN, RT
    INGLE, JN
    CREAGAN, ET
    FRYTAK, S
    KVOLS, LK
    RUBIN, J
    MCMAHON, RT
    CANCER TREATMENT REPORTS, 1978, 62 (05): : 843 - 844
  • [40] EFFECTS ON GROWTH AND CHROMOSOMES IN HUMAN HEMATOPOIETIC CELL LINES BY A NEW ANTITUMOR AGENT EPIPODOPHYLLOTOXIN (VP-16)
    HOU, Y
    HUANG, CC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 49 - &
12345